| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Division of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Minato-ku, 2 Department of Molecular Oncology, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, Bunkyo-ku, and 3 Department of Pathology, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan; 4 Department Research Laboratories, Shionogi & Co., Ltd., Fukushima-ku, Osaka, Japan; and 5 Laboratories for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan
Requests for reprints: Motoharu Seiki, Division of Cancer Cell Research, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan. Phone: 81-3-5449-5255; Fax: 81-3-5449-5414; E-mail: mseiki{at}ims.u-tokyo.ac.jp.
Matrix metalloproteinase-2 (MMP-2) is a stroma-derived MMP belonging to the type IV collagenase family. It is believed to mediate tumor cell behavior by degrading deposits of type IV collagen, a major component of the basement membrane. The membrane type 1-MMP (MT1-MMP) is a highly potent activator of MMP-2 and is expressed in many tumor and stromal cells. However, the roles played by stromal MMP-2 in tumor progression in vivo remain poorly understood. We established a colon epithelial cell line from an Mt1-mmp/ mouse strain and transfected these cells with an inducible expression system for MT1-MMP (MT1rev cells). Following s.c. implantation into Mmp-2+/+ mice and induction of MT1-MMP expression, MT1rev cells grew rapidly, whereas they grew very slowly in Mmp-2/ mice, even in the presence of MT1-MMP. This MT1-MMPdependent tumor growth of MT1rev cells was enhanced in Mmp-2/ mice as long as MMP-2 was supplied via transfection or coimplantation of MMP-2positive fibroblasts. MT1rev cells cultured in vitro in a three-dimensional collagen gel matrix also required the MT1-MMP/MMP-2 axis for rapid proliferation. MT1rev cells deposit type IV collagen primarily at the cell-collagen interface, and these deposits seem scarce at sites of invasion and proliferation. These data suggest that cooperation between stroma-derived MMP-2 and tumor-derived MT1-MMP may play a role in tumor invasion and proliferation via remodeling of the tumor-associated basement membrane. To our knowledge, this is the first study demonstrating that MT1-MMPdependent tumor growth in vivo requires stromal-derived MMP-2. It also suggests that MMP-2 represents a potential target for tumor therapeutics. [Cancer Res 2007;67(9):43119]
This article has been cited by other articles:
![]() |
T. Sakamoto and M. Seiki Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity Genes Cells, May 1, 2009; 14(5): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sabeh, R. Shimizu-Hirota, and S. J. Weiss Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited J. Cell Biol., April 6, 2009; 185(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Su, S. A. Blaine, D. Qiao, and A. Friedl Membrane Type 1 Matrix Metalloproteinase-Mediated Stromal Syndecan-1 Shedding Stimulates Breast Carcinoma Cell Proliferation Cancer Res., November 15, 2008; 68(22): 9558 - 9565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yoshida, N. Kajitani, A. Satsuka, H. Nakamura, and H. Sakai Ras Modifies Proliferation and Invasiveness of Cells Expressing Human Papillomavirus Oncoproteins J. Virol., September 1, 2008; 82(17): 8820 - 8827. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Itoh, N. Ito, H. Nagase, and M. Seiki The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface J. Biol. Chem., May 9, 2008; 283(19): 13053 - 13062. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, J. Xie, E. Rubin, Y.-X. Tang, F. Lin, X. Zi, and B. H. Hoang Frzb, a Secreted Wnt Antagonist, Decreases Growth and Invasiveness of Fibrosarcoma Cells Associated with Inhibition of Met Signaling Cancer Res., May 1, 2008; 68(9): 3350 - 3360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |